Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07425730

Early Myocardial Dysfunction Helps Identify Severe Refractory Pediatric Lupus

Myocardial Dysfunction in Pediatric Lupus

Status
Recruiting
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Shanghai Jiao Tong University School of Medicine · Academic / Other
Sex
All
Age
7 Years – 17 Years
Healthy volunteers
Accepted

Summary

To investigate biomarkers to identify pediatric SR-SLE patients by non-invasive echocardiographic techniques.

Detailed description

Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease. Although therapeutic advances have improved outcomes, a significant subset remains with severe disease activity despite optimal therapy, which is recognized as the severe refractory SLE (SR-SLE).A recent study using advanced echocardiographic techniques of global longitudinal strain (GLS) have revealed that left ventricular dysfunction is common in SLE patients and correlates with disease severity.The finding underscores the potential role of early myocardial dysfunction as a phenotypic marker of SR-SLE.To our knowledge, there are no validated biomarkers to reliably identify patients with SR-SLE at an early stage, especially in the pediatric population. Therefore, this study aimed to investigate biomarkers to identify pediatric SR-SLE patients.

Conditions

Timeline

Start date
2026-02-01
Primary completion
2026-07-01
Completion
2026-07-01
First posted
2026-02-23
Last updated
2026-02-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07425730. Inclusion in this directory is not an endorsement.